Elagolix
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 192 publications
Comparative post-marketing reporting signals of elagolix and myfembree in endometriosis: a FAERS pharmacovigilance study.
Journal: Frontiers in pharmacology
Published: April 20, 2026
New perspectives in managing chronic pelvic pain in endometriosis: the role of GnRH antagonists versus dienogest.
Journal: Expert opinion on pharmacotherapy
Published: April 10, 2026
Antagonizing the corticotropin-releasing hormone receptor 1 with an orally bioavailable drug reduces endometriosis pain and associated adhesions†.
Journal: Biology of reproduction
Published: March 16, 2026
Expert opinion by Federation of Obstetric and Gynaecological Societies of India on elagolix - Redefining the endometriosis therapy landscape.
Journal: European journal of obstetrics, gynecology, and reproductive biology
Published: March 04, 2026
Oral Gonadotropin-Releasing Hormone Antagonists for the Treatment of Endometriosis-Associated Pain: A Systematic Review and Meta-Analysis.
Journal: Journal of minimally invasive gynecology
Published: February 07, 2026
Safety of 48 months of elagolix with add-back therapy for endometriosis-associated pain.
Journal: AJOG global reports
Published: January 08, 2026
Single-Dose Bioequivalence Study of Elagolix Tablets 200 mg (Test Product) and Elagolix Tablets 200 mg (Reference Product) in Healthy Non-Pregnant, Non-Lactating Premenopausal Female Subjects Under Fasting Conditions.
Journal: Clinical pharmacology in drug development
Published: December 18, 2025
Bone mineral density with elagolix plus add-back therapy in women with heavy menstrual bleeding and uterine fibroids: open-label and post-treatment results of a 60-month phase 3 trial.
Journal: AJOG global reports
Published: December 01, 2025
Atypical gelation of Elagolix sodium in aqueous media: Mechanistic insights and Inhibition via coamorphization.
Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Published: October 15, 2025
Efficacy and Safety of Elagolix Versus Dienogest for Treatment of Moderate-to-Severe Endometriosis Pain: A Phase III, Multicentric, Double-Blind, Active-Controlled, Non-Inferiority Study.
Journal: BJOG : an international journal of obstetrics and gynaecology
Published: September 15, 2025
Insights on Medical Therapy for Uterine Fibroids: A Review.
Journal: Advances in therapy
Published: September 12, 2025
Last Updated: 06/30/2026